Transplant Diagnostics Market Size | Industry Analysis by 2027

Transplant Diagnostics Market to 2027- Global Analysis and Forecasts By Product & Services (Instruments, Reagents & Consumables, and Software & Services), Type (Solid Organ Transplantation, Soft Tissue Transplantation, and Stem Cell Transplantation), Technology (Molecular Assays and Non-Molecular Assays), Application (Diagnostic Applications and Research Applications), and End User (Hospitals & Transplant Centers, Research Laboratories & Academic Institutes, and Independent Reference Laboratories)

Publication Month : Apr 2019

  • Report Code : TIPRE00003076
  • Category : Biotechnology
  • Status : Published
  • No. of Pages : 150
Inquire Before Buy

PRICING

$4550

$2730

The transplant diagnostics market size was estimated to reach US$ 1,542.89 million by 2027 from US$ 789.88 million in 2018; it is estimated to grow at a CAGR of 7.9% during 2019-2027.

Transplant diagnostics refers to the diagnostics tests conducted on the organs meant to be transplanted. These tests are either conducted pre-transplantation or post-transplantation. Some of the common techniques used in transplant diagnostics are sequence-based molecular assays, PCR-based molecular assays, and non-molecular assays in certain cases. Transplant diagnostics is an essential factor in organ transplantation as it avoids any further complications that could occur after a transplant procedure.

The transplant diagnostics market growth is attributed to the rising prevalence of cardiovascular diseases and significant growth of biotechnology industry. However, expensive organ transplant surgeries may hinder the growth of market.

Lucrative Regions for Transplant Diagnostics Market

Lucrative Regions for Transplant Diagnostics Market
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities


Market Insights

Rising Prevalence of Cardiovascular Diseases

CVDs are the leading cause of death across the globe. The aging population commonly shows the structural and functional alteration of vessels accumulation through their life. Thus, it increases the risk of developing cardiovascular diseases. As per the American College of Cardiology, it is stated that CVD contributes nearly 800,000 deaths in the US, which is approximately one in every three deaths. The coronary heart disease (CHD) contributes to the majority of CVD deaths which is further followed by stroke and heart failure. Nearly over 90 million Americans get diagnosed with CVD. In addition, it is stated that at a global level cardiovascular disease contributes around 31% of all deaths and is expected that the cost of the CVD will be approximately to US$ 1,044 billion by 2030.

The CVD accounts for 45.0% of all deaths in Europe and 37.0% of all deaths in the EU. Owing to this, the need of transplant diagnostics for organ transplantation is likely to propel the market during the forecast period.

Product and Services-Based Insights

The global transplant diagnostics market, based on product and services, is segmented into instruments, reagents & consumables, and software & services. The reagents & consumables segment was the largest segment among the product and services subsegments in the transplant diagnostics market in 2018. However, the software & services segment is expected to witness growth in its demand at the fastest CAGR of 9.6% during 2019–2027.

Type-Based Insights

The global transplant diagnostics market, based on type, is segmented into solid organ transplantation, soft tissue transplantation, and stem cell transplantation. The solid organ transplantation segment held the largest share of the transplant diagnostics market in 2018 and is anticipated to continue to hold the largest market during the forecast period.

Technology-Based Insights

The global transplant diagnostics market, based on technology, is segmented into molecular assays and non-molecular assays. In 2018, the molecular assays systems segment held a larger share of the market and is expected to witness growth in its demand at a faster CAGR of 9.5% during 2019–2027.

Application-Based Insights

The global transplant diagnostics market, based on application, is segmented into diagnostic applications and research applications. In 2018, the diagnostic applications segment held a larger share of the market and is expected to grow at a faster rate during the coming years.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Transplant Diagnostics Market: Strategic Insights

transplant-diagnostics-market
Market Size Value inUS$ 789.88 Million in 2018
Market Size Value byUS$ 1,542.89 Million by 2027
Growth rateCAGR of 7.9% from 2019-2027
Forecast Period2019-2027
Base Year2019
Analyst Image

Akshay

Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst Image  Speak to Analyst

Product launches and approvals are commonly adopted strategies by companies to expand their global footprints and product portfolios. Moreover, the transplant diagnostics market players focus on the partnership strategy to enlarge their clientele, which, in turn, permits them to maintain their brand name across the world.

Company Profiles

  • BIO-RAD LABORATORIES, INC
  • BIOMÉRIEUX SA
  • ILLUMINA, INC.
  • THERMO FISHER SCIENTIFIC, INC.
  • QIAGEN N.V.
  • F. HOFFMANN-LA ROCHE LTD.
  • HOLOGIC INC.
  • LUMINEX CORPORATION
  • OMIXON INC.
  • ABBOTT
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

Product & Services , Type , Technology , Application , End User , and Geography

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

US, Canada, Mexico, UK, Germany, Spain, Italy, France, India, China, Japan, South Korea, Australia, UAE, Saudi Arabia, South Africa, Brazil, Argentina

Frequently Asked Questions


What are transplant diagnostics?

Transplant diagnostics refers to the diagnostics tests that are conducted on the organs that are meant to be transplanted. These tests are performed pre and post transplantation.

What are major common techniques used in transplant diagnostics?

Some of the common techniques used in transplant diagnostics include, sequence based molecular assays, and PCR based molecular assays and also non-molecular assays in certain cases.

Who are the key players in the transplant diagnostics market?

The major key players are Abbott, Illumina, Inc., Thermo Fisher Scientific Inc., QIAGEN, Omixon Inc., Hologic Inc., Luminex Corporation, F. Hoffmann-La Roche Ltd, bioMérieux SA.

1. INTRODUCTION

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 market segmentation

1.3.1 Global Transplant Diagnostics Market – By Product & Services

1.3.2 Global Transplant Diagnostics Market – By Type

1.3.3 Global Transplant Diagnostics Market – By Technology

1.3.4 Global Transplant Diagnostics Market – By Application

1.3.5 Global Transplant Diagnostics Market – By End User

1.3.6 Global Transplant Diagnostics Market – By Geography

2. Global Transplant Diagnostics Market – Key takeaways

3. Research Methodology

3.1.1 Coverage

3.1.2 Secondary Research

3.1.3 Primary Research

4. Global Transplant Diagnostics market – market landscape

4.1 overview

4.2 PEST Analysis

4.2.1 North America PEST Analysis

4.2.2 Europe PEST Analysis

4.2.3 Asia Pacific PEST Analysis

4.2.4 Middle East & Africa PEST Analysis

4.2.5 South & Central America PEST Analysis

5. Global transplant Diagnostics market – Key Market Dynamics

5.1 Key Market Drivers

5.1.1 Rising Prevalence of Cardiovascular Diseases

5.1.2 Significant Growth of Biotechnology Industries

5.1.3 Rising Need for The Organ Transplantation

5.1.4 Rising Cell Based Research Activities

5.2 Key Market Restraints

5.2.1 Expensive Organ Transplant Surgeries

5.2.2 Limited Numbers of Donors for Organ Transplant Surgeries

5.3 Key Market Opportunities

5.3.1 Growth Opportunities in Emerging Regions

5.4 Impact analysis

6. Transplant Diagnostics market – Global Analysis

6.1 global Transplant Diagnostics market Revenue Forecasts and Analysis

6.2 global Transplant Diagnostics market, By Geography - Forecasts and Analysis

6.3 PERFORMANCE OF KEY PLAYERS

6.3.1 Thermo Fisher Scientific Inc.

6.3.2 F. Hoffmann-La Roche Ltd

6.4 expert opinions

7. Global Transplant Diagnostics Market analysis– by Product & Services

7.1 overview

7.2 Global transplant diagnostics Market BY Product & Services, 2018 & 2027 (%)

7.3 Instruments Market

7.3.1 Overview

7.3.2 Global Instruments Market Revenue and Forecasts to 2027 (US$ Mn)

7.4 Reagents & Consumables market

7.4.1 Overview

7.4.2 Global Reagents & Consumables Market Revenue and Forecasts to 2027 (US$ Mn)

7.5 Softwate & Services maRKET

7.5.1 Overview

7.5.2 Global Software & Services Market Revenue and Forecasts to 2027 (US$ Mn)

8. global transplant Diagnostics Market analysis– by type

8.1 overview

8.2 Global transplant diagnostics Market, BY type 2018 & 2027 (%)

8.3 Solid Organ Transplantation market

8.3.1 Overview

8.3.2 Global Solid Organ Transplantation Market Revenue and Forecasts to 2027 (US$ Mn)

8.3.3 Lung Transplantation Market

8.3.3.1 Overview

8.3.3.2 Global Lung Transplantation Market Revenue and Forecasts to 2027 (US$ Mn)

8.3.4 Liver Transplantation Market

8.3.4.1 Overview

8.3.4.2 Global Liver Transplantation Market Revenue and Forecasts to 2027 (US$ Mn)

8.3.5 Kidney Transplantation Market

8.3.5.1 Overview

8.3.5.2 Global Kidney Transplantation Market Revenue and Forecasts to 2027 (US$ Mn)

8.3.6 Heart Transplantation Market

8.3.6.1 Overview

8.3.6.2 Global Heart Transplantation Market Revenue and Forecasts to 2027 (US$ Mn)

8.3.7 Other Solid Organ Transplantation Market

8.3.7.1 Overview

8.3.7.2 Global Other Solid Organ Transplantation Market Revenue and Forecasts to 2027 (US$ Mn)

8.4 Soft Tissue Transplantation market

8.4.1 Overview

8.4.2 Global Soft Tissue Transplantation Market Revenue and Forecasts to 2027 (US$ Mn)

8.5 Stem Cell transplantation market

8.5.1 Overview

8.5.2 Global Stem Cell Transplantation Market Revenue and Forecasts to 2027 (US$ Mn)

9. Global Transplant Diagnostics Market analysis– by Technology

9.1 overview

9.2 Global transplant diagnostics Market BY TECHNOLOGY, 2018 & 2027 (%)

9.3 Molecular Assays Market

9.3.1 Overview

9.3.2 Global Molecular Assays Market Revenue and Forecasts to 2027 (US$ Mn)

9.3.3 Sequencing-Based Molecular Assays Market

9.3.3.1 Overview

9.3.4 Global Sequencing-Based Molecular Assays Market Revenue and Forecasts to 2027 (US$ Mn)

9.3.4.1 Next-Generation Sequencing Market

9.3.4.1.1 Overview

9.3.4.1.2 Global Next-Generation Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)

9.3.4.2 Sanger Sequencing Market

9.3.4.2.1 Overview

9.3.4.2.2 Global Sanger Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)

9.3.4.3 Other Sequencing-Based Molecular Assays Market

9.3.4.3.1 Overview

9.3.4.3.2 Global Other Sequencing-Based Molecular Assays Market Revenue and Forecasts to 2027 (US$ Mn)

9.3.5 PCR-Based Molecular Assays Market

9.3.5.1 Overview

9.3.5.2 Global PCR-Based Molecular Assays Market Revenue and Forecasts to 2027 (US$ Mn)

9.3.5.3 Real Time PCR Market

9.3.5.3.1 Overview

9.3.5.3.2 Global Real Time PCR Market Revenue and Forecasts to 2027 (US$ Mn)

9.3.5.4 Sequence-Specific Primer-PCR Market

9.3.5.4.1 Overview

9.3.5.4.2 Global Sequence-Specific Primer-PCR Market Revenue and Forecasts to 2027 (US$ Mn)

9.3.5.5 Other PCR-Based Molecular Assays Market

9.3.5.5.1 Overview

9.3.5.5.2 Global Other PCR-Based Molecular Assays Market Revenue and Forecasts to 2027 (US$ Mn)

9.4 NON-Molecular Assays Market

9.4.1 Overview

9.4.2 Global NON-Molecular Assays Market Revenue and Forecasts to 2027 (US$ Mn)

10. global transplant Diagnostics Market analysis– by Application

10.1 overview

10.2 Global transplant diagnostics Market, BY Application 2018 & 2027 (%)

10.3 Diagnostic Applications market

10.3.1 Overview

10.3.2 Global Diagnostic Applications Market Revenue and Forecasts to 2027 (US$ Mn)

10.3.3 Pre-Transplantation Diagnostics Market

10.3.3.1 Overview

10.3.3.2 Global Pre-Transplantation Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

10.3.4 Post-Transplantation Diagnostics Market

10.3.4.1 Overview

10.3.4.2 Global Post-Transplantation Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

10.4 Research Applications market

10.4.1 Overview

10.4.2 Global Research Applications Market Revenue and Forecasts to 2027 (US$ Mn)

11. global transplant Diagnostics Market analysis– by ENd User

11.1 overview

11.2 Global transplant diagnostics Market, BY ENd User 2018 & 2027 (%)

11.3 hospitals & transplant centers market

11.3.1 Overview

11.3.2 Global Hospitals & Transplant Centers Market Revenue and Forecasts to 2027 (US$ Mn)

11.4 Research Laboratories & Academic Institutes market

11.4.1 Overview

11.4.2 Global Research Laboratories & Academic Institutes Market Revenue and Forecasts to 2027 (US$ Mn)

11.5 Independent Reference Laboratories market

11.5.1 Overview

11.5.2 Global Independent Reference Laboratories Market Revenue and Forecasts to 2027 (US$ Mn)

12. Transplant Diagnostics Market Revenue and Forecasts to 2027 – geographical analysis

12.1 North America Transplant Diagnostics market Revenue and Forecasts to 2027

12.1.1 North America Transplant Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

12.1.2 North America Transplant Diagnostics Market Revenue And Forecasts to 2027, By Product & Services (US$ Mn)

12.1.3 North America Transplant Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.1.3.1 North America Solid Organ Transplantation Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.1.4 North America Transplant Diagnostics Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

12.1.4.1 North America Molecular Assays Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.1.4.1.1 North America Sequencing-Based Molecular Assays Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.1.4.1.2 North America PCR-Based Molecular Assays Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.1.5 North America Transplant Diagnostics market Revenue And Forecasts to 2027, By Application (US$ Mn)

12.1.5.1 North America Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.1.6 North America Transplant Diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)

12.1.7 North America Transplant Diagnostics Market Revenue And Forecasts to 2027, By Country (%)

12.1.8 US Transplant Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

12.1.8.1 US Transplant Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

12.1.8.2 US Transplant Diagnostics Market Revenue And Forecasts to 2027, By Product & Services (US$ Mn)

12.1.8.3 US Transplant Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.1.8.3.1 US Solid Organ Transplantation Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.1.8.4 US Transplant Diagnostics Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

12.1.8.4.1 US Molecular Assays Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.1.8.4.1.1 US Sequencing-Based Molecular Assays Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.1.8.4.1.2 US PCR-Based Molecular Assays Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.1.8.5 US Transplant Diagnostics market Revenue And Forecasts to 2027, By Application (US$ Mn)

12.1.8.5.1 US Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.1.8.6 US Transplant Diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)

12.1.9 Canada Transplant Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

12.1.9.1 Canada Transplant Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

12.1.9.2 Canada Transplant Diagnostics Market Revenue And Forecasts to 2027, By Product & Services (US$ Mn)

12.1.9.3 Canada Transplant Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.1.9.3.1 Canada Solid Organ Transplantation Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.1.9.4 Canada Transplant Diagnostics Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

12.1.9.4.1 Canada Molecular Assays Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.1.9.4.1.1 Canada Sequencing-Based Molecular Assays Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.1.9.4.1.2 Canada PCR-Based Molecular Assays Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.1.9.5 Canada Transplant Diagnostics market Revenue And Forecasts to 2027, By Application (US$ Mn)

12.1.9.5.1 Canada Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.1.9.6 Canada Transplant Diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)

12.1.10 Mexico Transplant Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

12.1.10.1 Mexico Transplant Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

12.1.10.2 Mexico Transplant Diagnostics Market Revenue And Forecasts to 2027, By Product & Services (US$ Mn)

12.1.10.3 Mexico Transplant Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.1.10.3.1 Mexico Solid Organ Transplantation Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.1.10.4 Mexico Transplant Diagnostics Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

12.1.10.4.1 Mexico Molecular Assays Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.1.10.4.1.1 Mexico Sequencing-Based Molecular Assays Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.1.10.4.1.2 Mexico PCR-Based Molecular Assays Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.1.10.5 Mexico Transplant Diagnostics market Revenue And Forecasts to 2027, By Application (US$ Mn)

12.1.10.5.1 Mexico Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.1.10.6 Mexico Transplant Diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)

12.2 Europe Transplant Diagnostics market Revenue and Forecasts to 2027

12.2.1 Europe Transplant Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

12.2.2 Europe Transplant Diagnostics Market Revenue And Forecasts to 2027, By Product & Services (US$ Mn)

12.2.3 Europe Transplant Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.2.3.1 Europe Solid Organ Transplantation Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.2.4 Europe Transplant Diagnostics Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

12.2.4.1 Europe Molecular Assays Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.2.4.1.1 Europe Sequencing-Based Molecular Assays Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.2.4.1.2 Europe PCR-Based Molecular Assays Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.2.5 Europe Transplant Diagnostics market Revenue And Forecasts to 2027, By Application (US$ Mn)

12.2.5.1 Europe Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.2.6 Europe Transplant Diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)

12.2.7 Europe Transplant Diagnostics Market Revenue And Forecasts to 2027, By Country (%)

12.2.8 UK Transplant Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

12.2.8.1 UK Transplant Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

12.2.8.2 UK Transplant Diagnostics Market Revenue And Forecasts to 2027, By Product & Services (US$ Mn)

12.2.8.3 UK Transplant Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.2.8.3.1 UK Solid Organ Transplantation Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.2.8.4 UK Transplant Diagnostics Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

12.2.8.4.1 UK Molecular Assays Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.2.8.4.1.1 UK Sequencing-Based Molecular Assays Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.2.8.4.1.2 UK PCR-Based Molecular Assays Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.2.8.5 UK Transplant Diagnostics market Revenue And Forecasts to 2027, By Application (US$ Mn)

12.2.8.5.1 UK Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.2.8.6 UK Transplant Diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)

12.2.9 Germany Transplant Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

12.2.9.1 Germany Transplant Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

12.2.9.2 Germany Transplant Diagnostics Market Revenue And Forecasts to 2027, By Product & Services (US$ Mn)

12.2.9.3 Germany Transplant Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.2.9.3.1 Germany Solid Organ Transplantation Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.2.9.4 Germany Transplant Diagnostics Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

12.2.9.4.1 Germany Molecular Assays Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.2.9.4.1.1 Germany Sequencing-Based Molecular Assays Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.2.9.4.1.2 Germany PCR-Based Molecular Assays Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.2.9.5 Germany Transplant Diagnostics Market Revenue And Forecasts to 2027, By Application (US$ Mn)

12.2.9.5.1 Germany Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.2.9.6 Germany Transplant Diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)

12.2.10 France Transplant Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

12.2.10.1 France Transplant Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

12.2.10.2 France Transplant Diagnostics Market Revenue And Forecasts to 2027, By Product & Services (US$ Mn)

12.2.10.3 France Transplant Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.2.10.3.1 France Solid Organ Transplantation Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.2.10.4 France Transplant Diagnostics Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

12.2.10.4.1 France Molecular Assays Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.2.10.4.1.1 France Sequencing-Based Molecular Assays Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.2.10.4.1.2 France PCR-Based Molecular Assays Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.2.10.5 France Transplant Diagnostics market Revenue And Forecasts to 2027, By Application (US$ Mn)

12.2.10.5.1 France Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.2.10.6 France Transplant Diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)

12.2.11 Italy Transplant Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

12.2.11.1 Italy Transplant Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

12.2.11.2 Italy Transplant Diagnostics Market Revenue And Forecasts to 2027, By Product & Services (US$ Mn)

12.2.11.3 Italy Transplant Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.2.11.3.1 Italy Solid Organ Transplantation Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.2.11.4 Italy Transplant Diagnostics Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

12.2.11.4.1 Italy Molecular Assays Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.2.11.4.1.1 Italy Sequencing-Based Molecular Assays Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.2.11.4.1.2 Italy PCR-Based Molecular Assays Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.2.11.5 Italy Transplant Diagnostics market Revenue And Forecasts to 2027, By Application (US$ Mn)

12.2.11.5.1 Italy Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.2.11.6 Italy Transplant Diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)

12.2.12 Spain Transplant diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

12.2.12.1 Spain Transplant Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

12.2.12.2 Spain Transplant Diagnostics Market Revenue And Forecasts to 2027, By Product & Services (US$ Mn)

12.2.12.3 Spain Transplant Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.2.12.3.1 Spain Solid Organ Transplantation Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.2.12.4 Spain Transplant Diagnostics Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

12.2.12.4.1 Spain Molecular Assays Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.2.12.4.1.1 Spain Sequencing-Based Molecular Assays Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.2.12.4.1.2 Spain PCR-Based Molecular Assays Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.2.12.5 Spain Transplant Diagnostics market Revenue And Forecasts to 2027, By Application (US$ Mn)

12.2.12.5.1 Spain Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.2.12.6 Spain Transplant Diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)

12.3 Asia Pacific Transplant Diagnostics Market Revenue and Forecasts to 2027

12.3.1 Asia Pacific Transplant Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

12.3.2 Asia Pacific Transplant Diagnostics Market Revenue And Forecasts to 2027, By Product & Services (US$ Mn)

12.3.3 Asia Pacific Transplant Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.3.3.1 Asia Pacific Solid Organ Transplantation Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.3.4 Asia Pacific Transplant Diagnostics Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

12.3.4.1 Asia Pacific Molecular Assays Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.3.4.1.1 Asia Pacific Sequencing-Based Molecular Assays Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.3.4.1.2 Asia Pacific PCR-Based Molecular Assays Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.3.5 Asia Pacific Transplant Diagnostics market Revenue And Forecasts to 2027, By Application (US$ Mn)

12.3.5.1 Asia Pacific Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.3.6 Asia Pacific Transplant Diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)

12.3.7 Asia Pacific Transplant Diagnostics Market Revenue And Forecasts to 2027, By Country (%)

12.3.8 Japan Transplant Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

12.3.8.1 Japan Transplant Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

12.3.8.2 Japan Transplant Diagnostics Market Revenue And Forecasts to 2027, By Product & Services (US$ Mn)

12.3.8.3 Japan Transplant Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.3.8.3.1 Japan Solid Organ Transplantation Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.3.8.4 Japan Transplant Diagnostics Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

12.3.8.4.1 Japan Molecular Assays Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.3.8.4.1.1 Japan Sequencing-Based Molecular Assays Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.3.8.4.1.2 Japan PCR-Based Molecular Assays Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.3.8.5 Japan Transplant Diagnostics market Revenue And Forecasts to 2027, By Application (US$ Mn)

12.3.8.5.1 Japan Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.3.8.6 Japan Transplant Diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)

12.3.9 China Transplant Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

12.3.9.1 China Transplant Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

12.3.9.2 China Transplant Diagnostics Market Revenue And Forecasts to 2027, By Product & Services (US$ Mn)

12.3.9.3 China Transplant Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.3.9.3.1 China Solid Organ Transplantation Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.3.9.4 China Transplant Diagnostics Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

12.3.9.4.1 China Molecular Assays Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.3.9.4.1.1 China Sequencing-Based Molecular Assays Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.3.9.4.1.2 China PCR-Based Molsecular Assays Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.3.9.5 China Transplant Diagnostics market Revenue And Forecasts to 2027, By Application (US$ Mn)

12.3.9.5.1 China Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.3.9.6 China Transplant Diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)

12.3.10 India Transplant Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

12.3.10.1 India Transplant Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

12.3.10.2 India Transplant Diagnostics Market Revenue And Forecasts to 2027, By Product & Services (US$ Mn)

12.3.10.3 India Transplant Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.3.10.3.1 India Solid Organ Transplantation Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.3.10.4 India Transplant Diagnostics Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

12.3.10.4.1 India Molecular Assays Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.3.10.4.1.1 India Sequencing-Based Molecular Assays Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.3.10.4.1.2 India PCR-Based Molecular Assays Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.3.10.5 India Transplant Diagnostics market Revenue And Forecasts to 2027, By Application (US$ Mn)

12.3.10.5.1 India Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.3.10.6 India Transplant Diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)

12.3.11 South Korea Transplant Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

12.3.11.1 South Korea Transplant Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

12.3.11.2 South Korea Transplant Diagnostics Market Revenue And Forecasts to 2027, By Product & Services (US$ Mn)

12.3.11.3 South Korea Transplant Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.3.11.3.1 South Korea Solid Organ Transplantation Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.3.11.4 South Korea Transplant Diagnostics Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

12.3.11.4.1 South Korea Molecular Assays Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.3.11.4.1.1 South Korea Sequencing-Based Molecular Assays Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.3.11.4.1.2 South Korea PCR-Based Molecular Assays Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.3.11.5 South Korea Transplant Diagnostics market Revenue And Forecasts to 2027, By Application (US$ Mn)

12.3.11.5.1 South Korea Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.3.11.6 South Korea Transplant Diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)

12.3.12 Australia Transplant Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

12.3.12.1 Australia Transplant Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

12.3.12.2 Australia Transplant Diagnostics Market Revenue And Forecasts to 2027, By Product & Services (US$ Mn)

12.3.12.3 Australia Transplant Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.3.12.3.1 Australia Solid Organ Transplantation Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.3.12.4 Australia Transplant Diagnostics Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

12.3.12.4.1 Australia Molecular Assays Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.3.12.4.1.1 Australia Sequencing-Based Molecular Assays Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.3.12.4.1.2 Australia PCR-Based Molecular Assays Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.3.12.5 Australia Transplant Diagnostics market Revenue And Forecasts to 2027, By Application (US$ Mn)

12.3.12.5.1 Australia Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.3.12.6 Australia Transplant Diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)

12.4 Middle East & Africa Transplant Diagnostics Market Revenue and Forecasts to 2027

12.4.1 Middle East & Africa Transplant Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

12.4.2 Middle East & Africa Transplant Diagnostics Market Revenue And Forecasts to 2027, By Product & Services (US$ Mn)

12.4.3 Middle East & Africa Transplant Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.4.3.1 Middle East & Africa Solid Organ Transplantation Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.4.4 Middle East & Africa Transplant Diagnostics Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

12.4.4.1 Middle East & Africa Molecular Assays Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.4.4.1.1 Middle East & Africa Sequencing-Based Molecular Assays Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.4.4.1.2 Middle East & Africa PCR-Based Molecular Assays Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.4.5 Middle East & Africa Transplant Diagnostics market Revenue And Forecasts to 2027, By Application (US$ Mn)

12.4.5.1 Middle East & Africa Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.4.6 Middle East & Africa Transplant Diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)

12.4.7 Middle East & Africa Transplant Diagnostics Market Revenue and Forecasts to 2027, By Country (%)

12.4.8 UAE Transplant Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

12.4.8.1 UAE Transplant Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

12.4.8.2 UAE Transplant Diagnostics Market Revenue And Forecasts to 2027, By Product & Services (US$ Mn)

12.4.8.3 UAE Transplant Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.4.8.3.1 UAE Solid Organ Transplantation Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.4.8.4 UAE Transplant Diagnostics Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

12.4.8.4.1 UAE Molecular Assays Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.4.8.4.1.1 UAE Sequencing-Based Molecular Assays Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.4.8.4.1.2 UAE PCR-Based Molecular Assays Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.4.8.5 UAE Transplant Diagnostics market Revenue And Forecasts to 2027, By Application (US$ Mn)

12.4.8.5.1 UAE Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.4.8.6 UAE Transplant Diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)

12.4.9 Saudi Arabia Transplant Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

12.4.9.1 Saudi Arabia Transplant Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

12.4.9.2 Saudi Arabia Transplant Diagnostics Market Revenue And Forecasts to 2027, By Product & Services (US$ Mn)

12.4.9.3 Saudi Arabia Transplant Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.4.9.3.1 Saudi Arabia Solid Organ Transplantation Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.4.9.4 Saudi Arabia Transplant Diagnostics Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

12.4.9.4.1 Saudi Arabia Molecular Assays Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.4.9.4.1.1 Saudi Arabia Sequencing-Based Molecular Assays Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.4.9.4.1.2 Saudi Arabia PCR-Based Molecular Assays Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.4.9.5 Saudi Arabia Transplant Diagnostics market Revenue And Forecasts to 2027, By Application (US$ Mn)

12.4.9.5.1 Saudi Arabia Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.4.9.6 Saudi Arabia Transplant Diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)

12.4.10 South Africa Transplant Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

12.4.10.1 South Africa Transplant Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

12.4.10.2 South Africa Transplant Diagnostics Market Revenue And Forecasts to 2027, By Product & Services (US$ Mn)

12.4.10.3 South Africa Transplant Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.4.10.3.1 South Africa Solid Organ Transplantation Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.4.10.4 South Africa Transplant Diagnostics Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

12.4.10.4.1 South Africa Molecular Assays Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.4.10.4.1.1 South Africa Sequencing-Based Molecular Assays Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.4.10.4.1.2 South Africa PCR-Based Molecular Assays Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.4.10.5 South Africa Transplant Diagnostics market Revenue And Forecasts to 2027, By Application (US$ Mn)

12.4.10.5.1 South Africa Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.4.10.6 South Africa Transplant Diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)

12.5 South and Central America Transplant Diagnostics Market Revenue and Forecasts to 2027

12.5.1 South and Central America Transplant Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

12.5.2 South and Central America Transplant Diagnostics Market Revenue And Forecasts to 2027, By Product & Services (US$ Mn)

12.5.3 South and Central America Transplant Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.5.3.1 South and Central America Solid Organ Transplantation Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.5.4 South and Central America Transplant Diagnostics Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

12.5.4.1 South and Central America Molecular Assays Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.5.4.1.1 South and Central America Sequencing-Based Molecular Assays Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.5.4.1.2 South and Central America PCR-Based Molecular Assays Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.5.5 South and Central America Transplant Diagnostics market Revenue And Forecasts to 2027, By Application (US$ Mn)

12.5.5.1 South and Central America Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.5.6 South and Central America Transplant Diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)

12.5.7 South and Central America Transplant Diagnostics Market Revenue And Forecasts to 2027, By Country (%)

12.5.8 Argentina Transplant Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

12.5.8.1 Argentina Transplant Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

12.5.8.2 Argentina Transplant Diagnostics Market Revenue And Forecasts to 2027, By Product & Services (US$ Mn)

12.5.8.3 Argentina Transplant Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.5.8.3.1 Argentina Solid Organ Transplantation Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.5.8.4 Argentina Transplant Diagnostics Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

12.5.8.4.1 Argentina Molecular Assays Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.5.8.4.1.1 Argentina Sequencing-Based Molecular Assays Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.5.8.4.1.2 Argentina PCR-Based Molecular Assays Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.5.8.5 Argentina Transplant Diagnostics market Revenue And Forecasts to 2027, By Application (US$ Mn)

12.5.8.5.1 Argentina Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.5.8.6 Argentina Transplant Diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)

12.5.9 Brazil Transplant Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

12.5.9.1 Brazil Transplant Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

12.5.9.2 Brazil Transplant Diagnostics Market Revenue And Forecasts to 2027, By Product & Services (US$ Mn)

12.5.9.3 Brazil Transplant Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.5.9.3.1 Brazil Solid Organ Transplantation Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.5.9.4 Brazil Transplant Diagnostics Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

12.5.9.4.1 Brazil Molecular Assays Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.5.9.4.1.1 Brazil Sequencing-Based Molecular Assays Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.5.9.4.1.2 Brazil PCR-Based Molecular Assays Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.5.9.5 Brazil Transplant Diagnostics market Revenue And Forecasts to 2027, By Application (US$ Mn)

12.5.9.5.1 Brazil Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)

12.5.9.6 Brazil Transplant Diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)

13. Transplant Diagnostics market – Industry Landscape

13.1 Overview

13.2 Growth Strategies in the Transplant diagnostics market , 2015-2019

13.3 Organic Growth Strategies

13.3.1 Overview

13.4 Organic Growth Strategies in the transplant diagnostics Market , 2015-2019

13.4.1 Product Launches

13.4.2 Recent Product Launches By Players In The Transplant Diagnostics Market

13.4.3 Product Approvals

13.4.4 Recent Product Approvals By Players In The Transplant Diagnostics Market

13.5 Inorganic Growth Strategies

13.5.1 Overview

13.6 Inorganic Growth Strategies in the transplant diagnostics Market , 2015-2019

13.6.1 Partnerships

13.6.2 Recent Partnerships Between Players In The Transplant Diagnostics Market

13.6.3 Acquisitions & Collaborations

13.6.4 Recent Acquisitions & Collaborations By Players In The Transplant Diagnostics Market

14. Transplant Diagnostics Market–Key company profiles

14.1 Bio-Rad Laboratories, Inc.

14.1.1 Key Facts

14.1.2 Business Description

14.1.3 Financial Information

14.1.4 Product Portfolio

14.1.5 SWOT Analysis

14.1.6 Key Developments

14.2 bioMérieux SA

14.2.1 Key Facts

14.2.2 Business Description

14.2.3 Financial Information

14.2.4 Product Portfolio

14.2.5 SWOT Analysis

14.2.6 Key Developments

14.3 Illumina, Inc.

14.3.1 Key Facts

14.3.2 Business Description

14.3.3 Financial Overview

14.3.4 Product Portfolio

14.3.5 SWOT Analysis

14.3.6 Key Developments

14.4 Thermo Fisher Scientific, Inc.

14.4.1 Key Facts

14.4.2 Business Description

14.4.3 Financial Information

14.4.4 Product Portfolio

14.4.5 SWOT Analysis

14.4.6 Key Developments

14.5 Qiagen N.V.

14.5.1 Key Facts

14.5.2 Business Description

14.5.3 Financial Overview

14.5.4 Product Portfolio

14.5.5 SWOT Analysis

14.5.6 Key Developments

14.6 F. Hoffmann-La Roche Ltd.

14.6.1 Key Facts

14.6.2 Business Description

14.6.3 Financial Overview

14.6.4 Product Portfolio

14.6.5 SWOT Analysis

14.6.6 Key Developments

14.7 HOLOGIC INC.

14.7.1 Key Facts

14.7.2 Business Description

14.7.3 Financial Overview

14.7.4 Product Portfolio

14.7.5 SWOT Analysis

14.7.6 Key Developments

14.8 Luminex Corporation

14.8.1 Key Facts

14.8.2 Business Description

14.8.3 Financial Overview

14.8.4 Product Portfolio

14.8.5 SWOT Analysis

14.8.6 Key Developments

14.9 Omixon Inc.

14.9.1 Key Facts

14.9.2 Business Description

14.9.3 Financial Overview

14.9.4 Product Portfolio

14.9.5 SWOT Analysis

14.9.6 Key Developments

14.10 Abbott

14.10.1 Key Facts

14.10.2 Business Description

14.10.3 Financial Overview

14.10.4 Product Portfolio

14.10.5 SWOT Analysis

14.10.6 Key Developments

15. Appendix

15.1 About The Insight Partners

15.2 Glossary of Terms

list of tables

TABLE 1. North america Transplant Diagnostics market Revenue And Forecasts to 2027, By product & Services (US$ Mn)

TABLE 2. North America transplant diagnostics market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 3. North America Solid Organ Transplantation market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 4. North America transplant diagnostics market Revenue And Forecasts to 2027, By Technology (US$ Mn)

TABLE 5. North America molecular assays market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 6. North America Sequencing-Based Molecular Assays market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 7. North America PCR-Based Molecular Assays market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 8. North America Transplant Diagnostics market Revenue And Forecasts to 2027, By application (US$ Mn)

TABLE 9. North America Diagnostic Applications market Revenue And Forecasts to 2027, By type (US$ Mn)

TABLE 10. North America Transplant Diagnostics market Revenue And Forecasts to 2027, By end user (US$ Mn)

TABLE 11. US Transplant Diagnostics market Revenue And Forecasts to 2027, By product & Services (US$ Mn)

TABLE 12. US transplant diagnostics market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 13. US Solid Organ Transplantation market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 14. US transplant diagnostics market Revenue And Forecasts to 2027, By Technology (US$ Mn)

TABLE 15. US molecular assays market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 16. US Sequencing-Based Molecular Assays market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 17. US PCR-Based Molecular Assays market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 18. US Transplant Diagnostics market Revenue And Forecasts to 2027, By application (US$ Mn)

TABLE 19. US Diagnostic Applications market Revenue And Forecasts to 2027, By type (US$ Mn)

TABLE 20. US Transplant Diagnostics market Revenue And Forecasts to 2027, By end user (US$ Mn)

TABLE 21. Canada Transplant Diagnostics market Revenue And Forecasts to 2027, By product & Services (US$ Mn)

TABLE 22. Canada transplant diagnostics market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 23. Canada Solid Organ Transplantation market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 24. Canada transplant diagnostics market Revenue And Forecasts to 2027, By Technology (US$ Mn)

TABLE 25. Canada molecular assays market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 26. Canada Sequencing-Based Molecular Assays market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 27. Canada PCR-Based Molecular Assays market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 28. Canada Transplant Diagnostics market Revenue And Forecasts to 2027, By application (US$ Mn)

TABLE 29. Canada Diagnostic Applications market Revenue And Forecasts to 2027, By type (US$ Mn)

TABLE 30. Canada Transplant Diagnostics market Revenue And Forecasts to 2027, By end user (US$ Mn)

TABLE 31. Mexico Transplant Diagnostics market Revenue And Forecasts to 2027, By product & Services (US$ Mn)

TABLE 32. Mexico transplant diagnostics market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 33. Mexico Solid Organ Transplantation market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 34. Mexico transplant diagnostics market Revenue And Forecasts to 2027, By Technology (US$ Mn)

TABLE 35. Mexico molecular assays market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 36. Mexico Sequencing-Based Molecular Assays market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 37. Mexico PCR-Based Molecular Assays market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 38. Mexico Transplant Diagnostics market Revenue And Forecasts to 2027, By application (US$ Mn)

TABLE 39. Mexico Diagnostic Applications market Revenue And Forecasts to 2027, By type (US$ Mn)

TABLE 40. Mexico Transplant Diagnostics market Revenue And Forecasts to 2027, By end user (US$ Mn)

TABLE 41. Europe Transplant Diagnostics market Revenue And Forecasts to 2027, By product & Services (US$ Mn)

TABLE 42. Europe transplant diagnostics market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 43. Europe Solid Organ Transplantation market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 44. Europe transplant diagnostics market Revenue And Forecasts to 2027, By Technology (US$ Mn)

TABLE 45. Europe molecular assays market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 46. Europe Sequencing-Based Molecular Assays market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 47. Europe PCR-Based Molecular Assays market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 48. Europe Transplant Diagnostics market Revenue And Forecasts to 2027, By application (US$ Mn)

TABLE 49. Europe Diagnostic Applications market Revenue And Forecasts to 2027, By type (US$ Mn)

TABLE 50. Europe Transplant Diagnostics market Revenue And Forecasts to 2027, By end user (US$ Mn)

TABLE 51. UK Transplant Diagnostics market Revenue And Forecasts to 2027, By product & Services (US$ Mn)

TABLE 52. UK transplant diagnostics market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 53. UK Solid Organ Transplantation market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 54. UK transplant diagnostics market Revenue And Forecasts to 2027, By Technology (US$ Mn)

TABLE 55. UK molecular assays market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 56. UK Sequencing-Based Molecular Assays market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 57. UK PCR-Based Molecular Assays market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 58. UK Transplant Diagnostics market Revenue And Forecasts to 2027, By application (US$ Mn)

TABLE 59. UK Diagnostic Applications market Revenue And Forecasts to 2027, By type (US$ Mn)

TABLE 60. UK Transplant Diagnostics market Revenue And Forecasts to 2027, By end user (US$ Mn)

TABLE 61. Germany Transplant Diagnostics market Revenue And Forecasts to 2027, By product & Services (US$ Mn)

TABLE 62. Germany transplant diagnostics market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 63. Germany Solid Organ Transplantation market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 64. Germany transplant diagnostics market Revenue And Forecasts to 2027, By Technology (US$ Mn)

TABLE 65. Germany molecular assays market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 66. Germany Sequencing-Based Molecular Assays market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 67. Germany PCR-Based Molecular Assays market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 68. Germany Transplant Diagnostics market Revenue And Forecasts to 2027, By application (US$ Mn)

TABLE 69. Germany Diagnostic Applications market Revenue And Forecasts to 2027, By type (US$ Mn)

TABLE 70. Germany Transplant Diagnostics market Revenue And Forecasts to 2027, By end user (US$ Mn)

TABLE 71. France Transplant Diagnostics market Revenue And Forecasts to 2027, By product & Services (US$ Mn)

TABLE 72. France transplant diagnostics market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 73. France Solid Organ Transplantation market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 74. France transplant diagnostics market Revenue And Forecasts to 2027, By Technology (US$ Mn)

TABLE 75. France molecular assays market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 76. France Sequencing-Based Molecular Assays market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 77. France PCR-Based Molecular Assays market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 78. France Transplant Diagnostics market Revenue And Forecasts to 2027, By application (US$ Mn)

TABLE 79. France Diagnostic Applications market Revenue And Forecasts to 2027, By type (US$ Mn)

TABLE 80. France Transplant Diagnostics market Revenue And Forecasts to 2027, By end user (US$ Mn)

TABLE 81. Italy Transplant Diagnostics market Revenue And Forecasts to 2027, By product & Services (US$ Mn)

TABLE 82. Italy transplant diagnostics market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 83. Italy Solid Organ Transplantation market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 84. Italy transplant diagnostics market Revenue And Forecasts to 2027, By Technology (US$ Mn)

TABLE 85. Italy molecular assays market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 86. Italy Sequencing-Based Molecular Assays market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 87. Italy PCR-Based Molecular Assays market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 88. Italy Transplant Diagnostics market Revenue And Forecasts to 2027, By application (US$ Mn)

TABLE 89. Italy Diagnostic Applications market Revenue And Forecasts to 2027, By type (US$ Mn)

TABLE 90. Italy Transplant Diagnostics market Revenue And Forecasts to 2027, By end user (US$ Mn)

TABLE 91. Spain Transplant Diagnostics market Revenue And Forecasts to 2027, By product & Services (US$ Mn)

TABLE 92. Spain transplant diagnostics market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 93. Spain Solid Organ Transplantation market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 94. Spain transplant diagnostics market Revenue And Forecasts to 2027, By Technology (US$ Mn)

TABLE 95. Spain molecular assays market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 96. Spain Sequencing-Based Molecular Assays market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 97. Spain PCR-Based Molecular Assays market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 98. Spain Transplant Diagnostics market Revenue And Forecasts to 2027, By application (US$ Mn)

TABLE 99. Spain Diagnostic Applications market Revenue And Forecasts to 2027, By type (US$ Mn)

TABLE 100. Spain Transplant Diagnostics market Revenue And Forecasts to 2027, By end user (US$ Mn)

TABLE 101. North america Transplant Diagnostics market Revenue And Forecasts to 2027, By product & Services (US$ Mn)

TABLE 102. Asia Pacific transplant diagnostics market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 103. Asia Pacific Solid Organ Transplantation market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 104. Asia Pacific transplant diagnostics market Revenue And Forecasts to 2027, By Technology (US$ Mn)

TABLE 105. Asia Pacific molecular assays market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 106. Asia Pacific Sequencing-Based Molecular Assays market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 107. Asia Pacific PCR-Based Molecular Assays market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 108. Asia Pacific Transplant Diagnostics market Revenue And Forecasts to 2027, By application (US$ Mn)

TABLE 109. Asia Pacific Diagnostic Applications market Revenue And Forecasts to 2027, By type (US$ Mn)

TABLE 110. Asia Pacific Transplant Diagnostics market Revenue And Forecasts to 2027, By end user (US$ Mn)

TABLE 111. Japan Transplant Diagnostics market Revenue And Forecasts to 2027, By product & Services (US$ Mn)

TABLE 112. Japan transplant diagnostics market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 113. Japan Solid Organ Transplantation market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 114. Japan transplant diagnostics market Revenue And Forecasts to 2027, By Technology (US$ Mn)

TABLE 115. Japan molecular assays market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 116. Japan Sequencing-Based Molecular Assays market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 117. Japan PCR-Based Molecular Assays market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 118. Japan Transplant Diagnostics market Revenue And Forecasts to 2027, By application (US$ Mn)

TABLE 119. Japan Diagnostic Applications market Revenue And Forecasts to 2027, By type (US$ Mn)

TABLE 120. Japan Transplant Diagnostics market Revenue And Forecasts to 2027, By end user (US$ Mn)

TABLE 121. China Transplant Diagnostics market Revenue And Forecasts to 2027, By product & Services (US$ Mn)

TABLE 122. China transplant diagnostics market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 123. China Solid Organ Transplantation market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 124. China transplant diagnostics market Revenue And Forecasts to 2027, By Technology (US$ Mn)

TABLE 125. China molecular assays market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 126. China Sequencing-Based Molecular Assays market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 127. China PCR-Based Molecular Assays market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 128. China Transplant Diagnostics market Revenue And Forecasts to 2027, By application (US$ Mn)

TABLE 129. China Diagnostic Applications market Revenue And Forecasts to 2027, By type (US$ Mn)

TABLE 130. china Transplant Diagnostics market Revenue And Forecasts to 2027, By end user (US$ Mn)

TABLE 131. India Transplant Diagnostics market Revenue And Forecasts to 2027, By product & Services (US$ Mn)

TABLE 132. India transplant diagnostics market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 133. India Solid Organ Transplantation market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 134. India transplant diagnostics market Revenue And Forecasts to 2027, By Technology (US$ Mn)

TABLE 135. India molecular assays market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 136. India Sequencing-Based Molecular Assays market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 137. India PCR-Based Molecular Assays market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 138. India Transplant Diagnostics market Revenue And Forecasts to 2027, By application (US$ Mn)

TABLE 139. India Diagnostic Applications market Revenue And Forecasts to 2027, By type (US$ Mn)

TABLE 140. india Transplant Diagnostics market Revenue And Forecasts to 2027, By end user (US$ Mn)

TABLE 141. South Korea Transplant Diagnostics market Revenue And Forecasts to 2027, By product & Services (US$ Mn)

TABLE 142. South Korea transplant diagnostics market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 143. South Korea Solid Organ Transplantation market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 144. South Korea transplant diagnostics market Revenue And Forecasts to 2027, By Technology (US$ Mn)

TABLE 145. South Korea molecular assays market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 146. South Korea Sequencing-Based Molecular Assays market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 147. South Korea PCR-Based Molecular Assays market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 148. South Korea Transplant Diagnostics market Revenue And Forecasts to 2027, By application (US$ Mn)

TABLE 149. South Korea Diagnostic Applications market Revenue And Forecasts to 2027, By type (US$ Mn)

TABLE 150. South Korea Transplant Diagnostics market Revenue And Forecasts to 2027, By end user (US$ Mn)

TABLE 151. Australia Transplant Diagnostics market Revenue And Forecasts to 2027, By product & Services (US$ Mn)

TABLE 152. Australia transplant diagnostics market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 153. Australia Solid Organ Transplantation market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 154. Australia transplant diagnostics market Revenue And Forecasts to 2027, By Technology (US$ Mn)

TABLE 155. Australia molecular assays market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 156. Australia Sequencing-Based Molecular Assays market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 157. Australia PCR-Based Molecular Assays market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 158. Australia Transplant Diagnostics market Revenue And Forecasts to 2027, By application (US$ Mn)

TABLE 159. Australia Diagnostic Applications market Revenue And Forecasts to 2027, By type (US$ Mn)

TABLE 160. Australia Transplant Diagnostics market Revenue And Forecasts to 2027, By end user (US$ Mn)

TABLE 161. Middle East & Africa Transplant Diagnostics market Revenue And Forecasts to 2027, By product & Services (US$ Mn)

TABLE 162. Middle East & Africa transplant diagnostics market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 163. Middle East & Africa Solid Organ Transplantation market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 164. Middle East & Africa transplant diagnostics market Revenue And Forecasts to 2027, By Technology (US$ Mn)

TABLE 165. Middle East & Africa molecular assays market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 166. Middle East & Africa Sequencing-Based Molecular Assays market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 167. Middle East & Africa PCR-Based Molecular Assays market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 168. Middle East & Africa Transplant Diagnostics market Revenue And Forecasts to 2027, By application (US$ Mn)

TABLE 169. Middle East & Africa Diagnostic Applications market Revenue And Forecasts to 2027, By type (US$ Mn)

TABLE 170. Middle East & Africa Transplant Diagnostics market Revenue And Forecasts to 2027, By end user (US$ Mn)

TABLE 171. UAE Transplant Diagnostics market Revenue And Forecasts to 2027, By product & Services (US$ Mn)

TABLE 172. UAE transplant diagnostics market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 173. UAE Solid Organ Transplantation market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 174. UAE transplant diagnostics market Revenue And Forecasts to 2027, By Technology (US$ Mn)

TABLE 175. UAE molecular assays market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 176. UAE Sequencing-Based Molecular Assays market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 177. UAE PCR-Based Molecular Assays market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 178. UAE Transplant Diagnostics market Revenue And Forecasts to 2027, By application (US$ Mn)

TABLE 179. UAE Diagnostic Applications market Revenue And Forecasts to 2027, By type (US$ Mn)

TABLE 180. UAE Transplant Diagnostics market Revenue And Forecasts to 2027, By end user (US$ Mn)

TABLE 181. Saudi Arabia Transplant Diagnostics market Revenue And Forecasts to 2027, By product & Services (US$ Mn)

TABLE 182. Saudi Arabia transplant diagnostics market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 183. Saudi Arabia Solid Organ Transplantation market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 184. Saudi Arabia transplant diagnostics market Revenue And Forecasts to 2027, By Technology (US$ Mn)

TABLE 185. Saudi Arabia molecular assays market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 186. Saudi Arabia Sequencing-Based Molecular Assays market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 187. Saudi Arabia PCR-Based Molecular Assays market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 188. Saudi Arabia Transplant Diagnostics market Revenue And Forecasts to 2027, By application (US$ Mn)

TABLE 189. Saudi Arabia Diagnostic Applications market Revenue And Forecasts to 2027, By type (US$ Mn)

TABLE 190. Saudi Arabia Transplant Diagnostics market Revenue And Forecasts to 2027, By end user (US$ Mn)

TABLE 191. South Africa Transplant Diagnostics market Revenue And Forecasts to 2027, By product & Services (US$ Mn)

TABLE 192. South Africa transplant diagnostics market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 193. South Africa Solid Organ Transplantation market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 194. South Africa transplant diagnostics market Revenue And Forecasts to 2027, By Technology (US$ Mn)

TABLE 195. South Africa molecular assays market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 196. South Africa Sequencing-Based Molecular Assays market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 197. South Africa PCR-Based Molecular Assays market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 198. South Africa Transplant Diagnostics market Revenue And Forecasts to 2027, By application (US$ Mn)

TABLE 199. South Africa Diagnostic Applications market Revenue And Forecasts to 2027, By type (US$ Mn)

TABLE 200. South Africa Transplant Diagnostics market Revenue And Forecasts to 2027, By end user (US$ Mn)

TABLE 201. South and Central america Transplant Diagnostics market Revenue And Forecasts to 2027, By product & Services (US$ Mn)

TABLE 202. South and Central America transplant diagnostics market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 203. South and Central America Solid Organ Transplantation market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 204. South and Central America transplant diagnostics market Revenue And Forecasts to 2027, By Technology (US$ Mn)

TABLE 205. South and Central America molecular assays market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 206. South and Central America Sequencing-Based Molecular Assays market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 207. South and Central America PCR-Based Molecular Assays market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 208. South and Central America Transplant Diagnostics market Revenue And Forecasts to 2027, By application (US$ Mn)

TABLE 209. South and Central America Diagnostic Applications market Revenue And Forecasts to 2027, By type (US$ Mn)

TABLE 210. South and Central America Transplant Diagnostics market Revenue And Forecasts to 2027, By end user (US$ Mn)

TABLE 211. Argentina Transplant Diagnostics market Revenue And Forecasts to 2027, By product & Services (US$ Mn)

TABLE 212. Argentina transplant diagnostics market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 213. Argentina Solid Organ Transplantation market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 214. Argentina transplant diagnostics market Revenue And Forecasts to 2027, By Technology (US$ Mn)

TABLE 215. Argentina molecular assays market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 216. Argentina Sequencing-Based Molecular Assays market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 217. Argentina PCR-Based Molecular Assays market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 218. Argentina Transplant Diagnostics market Revenue And Forecasts to 2027, By application (US$ Mn)

TABLE 219. Argentina Diagnostic Applications market Revenue And Forecasts to 2027, By type (US$ Mn)

TABLE 220. Argentina Transplant Diagnostics market Revenue And Forecasts to 2027, By end user (US$ Mn)

TABLE 221. Brazil Transplant Diagnostics market Revenue And Forecasts to 2027, By product & Services (US$ Mn)

TABLE 222. Brazil transplant diagnostics market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 223. Brazil Solid Organ Transplantation market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 224. Brazil transplant diagnostics market Revenue And Forecasts to 2027, By Technology (US$ Mn)

TABLE 225. Brazil molecular assays market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 226. Brazil Sequencing-Based Molecular Assays market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 227. Brazil PCR-Based Molecular Assays market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 228. Brazil Transplant Diagnostics market Revenue And Forecasts to 2027, By application (US$ Mn)

TABLE 229. Brazil Diagnostic Applications market Revenue And Forecasts to 2027, By type (US$ Mn)

TABLE 230. Brazil Transplant Diagnostics market Revenue And Forecasts to 2027, By end user (US$ Mn)

TABLE 231. Recent product launches in the Transplant Diagnostics market , 2015-2019

TABLE 232. Recent Product Approvals in the Transplant Diagnostics market , 2015-2019

TABLE 233. Recent Partnerships in the Transplant Diagnostics market , 2015-2019

TABLE 234. Recent Acquisitions & Collaborations in the Transplant Diagnostics market , 2015-2019

TABLE 235. Glossary of Terms, Transplant Diagnostics market

list of figures

FIGURE 1. Transplant Diagnostics market Segmentation

FIGURE 2. Transplant Diagnostics Segmentation, by region

FIGURE 3. Asia Pacific Transplant Diagnostics market, Revenue (US$ Mn), By Geography 2018 & 2027

FIGURE 4. Global Transplant Diagnostics Market By product & Services, Market Share (%), 2018

FIGURE 5. Global Transplant Diagnostics Market By TYpe, Market Share (%), 2018

FIGURE 6. Global Transplant Diagnostics Market By technology, Market Share (%), 2018

FIGURE 7. Global Transplant Diagnostics Market By application, Market Share (%), 2018

FIGURE 8. Global Transplant Diagnostics Market By end user, Market Share (%), 2018

FIGURE 9. North America : PEST Analysis

FIGURE 10. Europe : PEST Analysis

FIGURE 11. Asia - Pacific : PEST Analysis

FIGURE 12. Middle East & Africa : PEST Analysis

FIGURE 13. South & Central America : PEST Analysis

FIGURE 14. transplant diagnostics market impact analysis of driver and Challenges

FIGURE 15. global Transplant Diagnostics market – Revenue Forecasts and Analysis – 2018- 2027

FIGURE 16. global Transplant Diagnostics market – by geography Forecasts and Analysis – 2018- 2027

FIGURE 17. Global Transplant diagnostics Market, by product & services 2018 & 2027 (%)

FIGURE 18. Global Instruments Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 19. Global reagents & consumables Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 20. Global software & Services Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 21. global transplant diagnostics Market, by type 2018 & 2027 (%)

FIGURE 22. global Solid organ transplantation Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 23. global lung transplantation Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 24. global liver transplantation Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 25. global kidney transplantation Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 26. global heart transplantation Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 27. global Other Solid Organ transplantation Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 28. global soft tissue transplantation Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 29. global Stem Cell Transplantation Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 30. Global Transplant diagnostics Market, by technology 2018 & 2027 (%)

FIGURE 31. Global Molecular Assays Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 32. Global sequencing-based molecular assays Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 33. Global Next-Generation Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 34. Global Sanger Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 35. Global Other Sequencing-Based Molecular Assays Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 36. Global PCR-based molecular assays Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 37. Global Real Time PCR Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 38. Global Sequence-Specific Primer-PCR Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 39. Global Other PCR-Based Molecular Assays Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 40. Global NON-Molecular Assays Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 41. global transplant diagnostics Market, by Application 2018 & 2027 (%)

FIGURE 42. global Diagnostic Applications Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 43. global Pre-Transplantation Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 44. global Post-Transplantation Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 45. global Research Applications Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 46. global transplant diagnostics Market, by ENd User 2018 & 2027 (%)

FIGURE 47. global Hospitals & Transplant Centers Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 48. global Research Laboratories & Academic Institutes Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 49. global Independent Reference Laboratories Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 50. North america Transplant Diagnostics Market REVENUE, by Country, 2018 (US$ MN)

FIGURE 51. North america Transplant Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 52. North America Transplant Diagnostics Market Revenue And Forecasts to 2027, By Country (%)

FIGURE 53. US Transplant Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 54. Canada Transplant Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 55. Mexico Transplant Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 56. Europe Transplant Diagnostics Market REVENUE, by Country, 2018 (US$ MN)

FIGURE 57. Europe Transplant Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 58. Europe Transplant Diagnostics Market Revenue And Forecasts to 2027, By Country (%)

FIGURE 59. UK Transplant Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 60. Germany Transplant Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 61. France Transplant Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 62. Italy Transplant Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 63. Spain Transplant Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 64. Asia Pacific Transplant Diagnostics Market REVENUE, by Country, 2018 (US$ MN)

FIGURE 65. Asia Pacific Transplant Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 66. asia pacific Transplant Diagnostics Market Revenue And Forecasts to 2027, By Country (%)

FIGURE 67. Japan Transplant Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 68. China Transplant Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 69. India Transplant Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 70. South Korea Transplant Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 71. Australia Transplant Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 72. Middle East & Africa Transplant Diagnostics Market REVENUE, by Country, 2018 (US$ MN)

FIGURE 73. Middle East & Africa Transplant Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 74. Middle East & Africa Transplant Diagnostics Market Revenue And Forecasts to 2027, By Country (%)

FIGURE 75. UAE Transplant Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 76. Saudi Arabia Transplant Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 77. South Africa Transplant Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 78. South and Central america Transplant Diagnostics Market REVENUE, by Country, 2018 (US$ MN)

FIGURE 79. South and Central america Transplant Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 80. South and Central America Transplant Diagnostics Market Revenue And Forecasts to 2027, By Country (%)

FIGURE 81. Argentina Transplant Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 82. Brazil Transplant Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 83. Growth Strategies in the Transplant diagnostics market , 2015-2019

FIGURE 84. Organic Growth Strategies in the transplant diagnostics market , 2015-2019

FIGURE 85. Inorganic Growth Strategies in the transplant diagnostics market , 2015-2019

The List of Companies
  1. Thermo Fisher Scientific Inc.
  2. Abbott
  3. Illumina, Inc.
  4. F. Hoffmann-La Roche Ltd
  5. Bio-Rad Laboratories, Inc.
  6. bioMérieux SA
  7. QIAGEN
  8. Hologic Inc.
  9. Luminex Corporation
  10. Omixon Inc.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Transplant Diagnostics Market